Stock Market Stories and Insights

<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;padding-top: 10px;;'>GT</div>
  over a week ago at Macroaxis 
By Ellen Johnson
While some millenniums are indifferent towards consumer cyclical space, it makes sense to review The Goodyear Tire. What exactly are Goodyear Tire shareholders getting in August? Is the entity valuation sustainable? Here I will cover a perspective on valuation of Goodyear to give you a better outlook on taking a position in this stock.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>FC</div>
  over a week ago at Macroaxis 
By Ellen Johnson
With so much uncertainty about the consumer cyclical space, it is fair to review Fiat Chrysler against current market trends. As we have suggested previously, Fiat Chrysler is beginning its reset as private investors shift to be more bearish due to the increased sector volatility. Fiat Chrysler Automo actively responds to the market. Large number of the gravitations of the company stock price movements has been a demonstration of what is happening in the market overall. Stable basic indicators of the firm may call for signs of short-horizon price drift for private investors. Fiat Chrysler Automo is scheduled to announce its earnings today. The next earnings report is expected on the 29th of October 2020.
<div class='circular--portrait-small' style='font-weight: 700;background:#689CFD;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>SB</div>
  over a week ago at Macroaxis 
By Vlad Skutelnik
As many rational traders are trying to avoid consumer defensive space, it makes sense to go over Spectrum Brands Holdings a little further and understand how it stands against Barnes Noble and other similar entities. We are going to analyze some of the competitive aspects of both Spectrum and Barnes.
<div class='circular--portrait-small' style='font-weight: 700;background:#347AFC;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>AR</div>
  over a week ago at Macroaxis 
By Ellen Johnson
While many traders are getting carried away by overanalyzing competition within energy space, it is quite reasonable to go over both, Archrock and Franks International as potential short-term investments. We are going to analyze some of the competitive aspects of both Archrock and Franks.
<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;padding-top: 10px;;'>IM</div>
  over a week ago at Macroaxis 
By Achuva Shats
While some of us are excited about healthcare space, it makes sense to outline ImmunoGen in greater detail to make a better perception of its potential. As expected, ImmunoGen is starting to reaffirm its true potential as institutional investors are becoming more and more confident in the future outlook. The company returns are very sensitive to each other to returns on the market. As market twists, the company is expected to follow. Conflicting basic indicators of the company may also entail signs of long-standing losses for ImmunoGen institutional investors. ImmunoGen is scheduled to announce its earnings today. The next earnings report is expected on the 6th of November 2020.
<div class='circular--portrait-small' style='font-weight: 700;background:#000000;color: #f2f2f2;font-size:0.9em;padding-top: 12px;;'>ABB</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
AbbVie Cash and Equivalents Turnover is fairly stable at the moment as compared to the past year. AbbVie reported Cash and Equivalents Turnover of 1.41 in 2019. Return on Investment is likely to grow to 30.15 in 2020, whereas Revenue Per Employee is likely to drop slightly above 948.3 K in 2020. AbbVie Inc is scheduled to announce its earnings today. The next earnings report is expected on the 6th of November 2020. Is healthcare space attracting new sophisticated investors, let's check if AbbVie Inc is sending any bullish signals. We will evaluate why we are still confident in anticipation of a recovery. We currently estimate AbbVie as undervalued. The real value is approaching 107.11 per share.
<div class='circular--portrait-small' style='font-weight: 700;background:#006400;color: #FFE4E1;font-size:1.1em;padding-top: 10px;;'>SM</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
The fundamental goal of this short article is to break down our forecasting of Shell for investors. We will try to forecast Shell Midstream outlook for August.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;padding-top: 10px;;'>BF</div>
  over a week ago at Macroaxis 
By Ellen Johnson
Bel Fuse is scheduled to announce its earnings today. Bel Fuse Average Assets are projected to increase significantly based on the last few years of reporting. The past year's Average Assets were at 451.79 Million. The current year Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to grow to about 18.9 M, whereas Earnings before Tax are forecasted to decline to (7.5 M). As many investors are getting excited about technology space, it is fair to go over Bel Fuse as an investment option. We will check if the company can maintain a respectable level of debt while minimizing operating losses.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;padding-top: 10px;;'>PI</div>
  over a week ago at Macroaxis 
By Achuva Shats
It looks like Twilio will continue to recover much faster as its share price surged up 1.07% today to PINTEREST INC's 4.9583%. As many rational traders are trying to avoid communication services space, it makes sense to sum up PINTEREST INC a little further and understand how it stands against Twilio and other similar entities. We are going to discuss some of the competitive aspects of both PINTEREST and Twilio.
<div class='circular--portrait-small' style='font-weight: 700;background:#8B008B;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>BG</div>
  over a week ago at Macroaxis 
By Raphi Shpitalnik
Given the investment horizon of 60 days, Berry Global is expected to generate 1.67 times more return on investment than the market. However, the company is 1.67 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The DOW is currently generating roughly 0.11 per unit of risk. While some risk-loving traders are indifferent towards current market volatility, it is reasonable to break down the risk of investing in Berry Global Group. We will go over odds for Berry Global to generate above-average margins in two-three weeks. Berry Global's low volatility may still impact the value of the stock as we estimate it as currently undervalued. The real value, based on our analysis, is getting close to 50.28 per share.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page